Subtypes of T-cell chronic lymphatic leukemia

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• T-cell chronic lymphatic leukemia (T-CLL) is a rare lymphoid malignancy.
• Distinguishing T-CLL subtypes is crucial for understanding disease behavior and prognosis.

Purpose of the Study:

• To present thirteen cases of T-cell chronic lymphatic leukemia (T-CLL).
• To classify T-CLL into distinct subtypes based on cellular morphology and function.
• To compare the therapeutic response and prognosis of T-CLL with B-cell chronic lymphatic leukemia (B-CLL).

Main Methods:

• Morphological analysis using light and electron microscopy.
• Functional assays including B-lymphocyte differentiation, Ig-secretion, natural killing, and antibody-dependent cytotoxicity.
• Cytochemical staining (acid phosphatase and non-specific esterase).
• Membrane marker investigations and Fc receptor analysis.

Main Results:

• Five subtypes of T-CLL were identified: prolymphocytic, lymphocytic (small), Sézary-like, abundant cytoplasm, and abundant cytoplasm with granules.
• Cytochemistry and membrane markers aided in T-CLL diagnosis and subtype differentiation.
• Functional studies revealed T-CLL cells with helper functions, cytotoxic activity, and Fc mu-receptor expression.
• Prognosis and response to therapy were generally poor for T-CLL compared to B-CLL.

Conclusions:

• T-cell chronic lymphatic leukemia exhibits diverse subtypes with distinct morphological and functional characteristics.
• Accurate subtyping of T-CLL is achievable through integrated morphological, cytochemical, and immunological methods.
• T-CLL generally presents a poorer prognosis and therapeutic response than B-CLL.